From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,958,154 shares, representing 0.75% for CNY 122.88 million under the buyback announced on July 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.93 CNY | +0.45% | -1.26% | +30.14% |
26/04 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
25/04 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.14% | 310.24Cr | |
-5.43% | 18TCr | |
+4.30% | 11TCr | |
-3.09% | 6.83TCr | |
+5.86% | 5.22TCr | |
+8.15% | 4.43TCr | |
+6.67% | 4.27TCr | |
+25.54% | 3.25TCr | |
+20.03% | 2.6TCr | |
+1.00% | 2.59TCr |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.